Harbor Capital Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
52,337
-5,940
-10% -$249K 0.21% 120
2026
Q1
$1.88M Buy
+58,277
New +$2.16M 0.15% 199
2025
Q1
– Sell
-34,745
Closed -$1.38M – 1545
2024
Q4
$1.38M Sell
34,745
-136,089
-80% -$5.15M 0.06% 390
2024
Q3
$5.82M Buy
170,834
+108,148
+173% +$3.04M 0.25% 121
2024
Q2
$1.36M Buy
62,686
+53,784
+604% +$1.13M 0.1% 282
2024
Q1
$197K Buy
+8,902
New +$217K 0.03% 603
2023
Q3
– Sell
-1,500
Closed -$38.2K – 644
2023
Q2
$38.2K Buy
+1,500
New +$36.4K 0.01% 519

Other funds holding VCYT

Harbor Capital Advisors's VCYT Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Veracyte (VCYT) stake by 10% in Q2 2026, selling an estimated $249K and leaving 52,337 shares worth $3.07M. The position accounts for 0.21% of the portfolio, ranked #120.

Harbor Capital Advisors first reported a position in VCYT in Q2 2023 and has held it in 7 quarters since. The position peaked at $5.82M in Q3 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Harbor Capital Advisors held 52,337 shares of Veracyte worth $3.07M as of Q2 2026.
  • Harbor Capital Advisors sold 5,940 Veracyte shares in Q2 2026, an estimated $249K.
  • Veracyte made up 0.21% of Harbor Capital Advisors's portfolio in Q2 2026, its #120 holding.
  • Harbor Capital Advisors first reported a position in Veracyte in Q2 2023 and has held it in 7 quarters since.
  • Harbor Capital Advisors's Veracyte position peaked at $5.82M in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.